Clinical Trials Directory

Trials / Unknown

UnknownNCT04932954

Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
LI YAN · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a hospital-based retrospective cohort study and the Immunohematologic characteristics of COVID-19 patients will be investigated systematically.

Detailed description

This is a hospital-based retrospective cohort study and the Immunohematologic characteristics of COVID-19 patients will be investigated systematically. In this study, we will seek to understand the association between SARS-CoV-2 infection and blood groups and explore the Anti-A and Anti-B effects in COVID-19 patients with graded severity. We will analyze the transfusion requirement and the clinical recurrences of COVID-19 patients. The discrepancy of blood group phenotypes in COVID-19 patients with graded severity will be also analyzed on the molecular level. This retrospective cohort study was conducted using electronic health recording data in Tongji Hospital. The clinical characteristics for all eligible patients will be retrieved. The records will be verified to avoid possible bias. Data collection was carried out independently by two investigators and reviewed by two different investigators.

Conditions

Timeline

Start date
2020-01-01
Primary completion
2022-01-01
Completion
2023-01-01
First posted
2021-06-21
Last updated
2021-06-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04932954. Inclusion in this directory is not an endorsement.